Close Menu

NEW YORK (GenomeWeb) – Genetic Technologies said today that its CLIA lab subsidiary Phenogen will be working with two cancer centers — Memorial Sloan Kettering in New York and the University of Cambridge in the UK — to study how polygenic risk scores impact the therapy decisions made by women who are BRCA mutation carriers.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

According to New Scientist, GEDmatch changed its terms and conditions over the weekend to opt its users out of law enforcement searches.

The Atlantic looks into time spent pursuing gene leads generated through candidate gene studies.

A twin study uncovers evidence that genes may influence whether someone gets a dog, Martha Stewart reports.

In PNAS this week: Cdx2 cells can help regenerate heart tissue in mice following a heart attack, PIWI-interacting small RNA levels in human cancer, and more.